4
Changes in Ownership
Wave Life Sciences, Inc. Filed Acc 0000899243-23-005562
Chief Financial Officer sold 9,729 shares at $4.04 ($39,305)
From the SEC's structured data for this filing
Trades in this filing
Moran Kyle · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-16 | Sale : show line 1 in the form | −9,729 | $4.04 | $39,305 | 79,751 | D |
| Open-market sales · 9,729 sh · avg $4.04 · $39,305 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-17 | Grant or award : show line 2 in the form Share Option (right to buy) | +272,700 | 272,700 | D |
Loading xslF345X03/doc4.xml…